Shoppers Drug Mart Corp (SC.TO) Buy, Sell or…

Home

Daily Stock Opinions and Ratings

Shoppers Drug Mart Corp (SC.TO)

0.00

-0.00 (0.00%)

55 watching

PAST TOP PICK

(A Top Pick July 5/06. Up 13%.) Was undervalued when he picked it. Still likes.

BUY

Good defensive play. Will continue to grow. The demographics are good. Their health and beauty aids is a high margin business.

HOLD

A defensive stock. When the economy turns down, people still go in to drugstores. It is also a growth stock. From a valuation point of view, it might be fully priced, up from a technical point of view it may have broken out.

TOP PICK

Not cheap, but the earnings visibility is wonderful. Lots more room for growth of new stores as well as revamping what they have and driving more sales per square foot. Relatively safe in an economic downturn.

DON'T BUY

His model price is $37.02, a 20% negative differential. Very expensive. The model price has been going down somewhat.

WEAK BUY

Fantastically managed. A stock that people go into as a defence, the way they used to go into Loblaws (L-T). Expensive, but expect it will get more expensive.

PAST TOP PICK

(A Top Pick Aug 18/05. Up 8.8%.) Was a pick because the growth was going that are but the stock wasn't doing much. Finally, in the last few weeks, there has been a strong recovery.

BUY

A good time to be in defensive plays and this one would fit in that category. Not a high dividend yielding stock, but the shares should do well.

TOP PICK

Management is focused, Canadian marketplace, run efficiently. Half the revenue is from the pharmacy, which is a big competitive advantage for them. They are adding 10% square footage growth every year over the next seven years. Beauty/cosmetics is a big business with high margins.

SELL

Looks a little expensive on a multiple basis. He has taken some profits recently. Dividend is minimal and he thinks the market will punish low dividend stocks.

WATCH

Expensive at 20/22 X earnings. Earnings are up 17 to 18% next year over this year. Try to buy in the $40/$42 range.

BUY

This is a “go to” stock for a defensive play. An excellent franchise. Continues to increase sales per square foot.

BUY

Earnings just came out and they had a good quarter. Continue to deliver on the earnings growth. Can see growth at 12/15% over 3 to 4 years at least. A defensive sector.

TOP PICK

Same store sales growth is attractive. Continues to add square footage. No hint of competition coming from the US. Great locations.

BUY

Excellent defensive play. Just reported quarterly earnings that were superb. Lagging in part because of the drug bill Ontario is passing. Will have less impact than expected. Trades at a discount to its peers in the US with significantly higher margins.

Showing 286 to 300 of 452 entries

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Shoppers Drug Mart Corp (SC.TO)